2 hasil untuk "Addy, Grace"
Menampilkan 1–2 · 0,31 detik · RSS
-
Artikel Jurnal Teks lengkap
Real‐World Clinical Experience With Sodium Phenylbutyrate and Taurursodiol at a Single Amyotrophic Lateral Sclerosis Center in the United States
INTRODUCTION/AIMS: Sodium phenylbutyrate (PB) and taurursodiol (TURSO)—PB and TURSO—was approved as a treatment for amyotrophic lateral sclerosis (ALS) in the United States in 2022 based on the results of a phase 2 trial, but was voluntarily withdrawn from the market in 2024 after negative results…
-
Artikel Jurnal Teks lengkap
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral Sclerosis
AIMS: RNS60 is an investigational product in clinical development for amyotrophic lateral sclerosis (ALS). RNS60 slowed disease progression in the ALS SOD1(G93A) mouse model and was safe and well tolerated both in an open‐label pilot study and a randomized, placebo‐controlled, multicenter phase 2…